StockData
HCA Healthcare, Inc. logo

HCA Healthcare, Inc. (HCA) stock analysis

HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/302% above fair value
$506.04+1.62 (+0.32%)

Close on Nov 11, 2026Market cap $105.71BP/E 16.8Yield 0.57%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance2Health1Dividend3

Mixed9 of 30 checks passed

HCA Healthcare passes 9 of the 30 checks behind our score; 7 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
2/6
Financial health
1/6
Dividend
3/6

What stands out

  • Earnings grew over 5 years

    Net income grew 12.6% a year on average over the last five fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 13.9% a year over the last three fiscal years.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 22.1% of total debt.

  • P/E below the industry

    HCA Healthcare's P/E of 16.8 is below the Health Services median of 23.9.

What to watch

  • Margin of safety under 20%

    The price is 2.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $506.04 is above our fair value estimate of $495.17.

  • Revenue growing under 10% a year

    Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.

  • Earnings growth not accelerating

    Net income grew 6.8% over the last twelve months, against a 5-year average of 12.6% a year.

Valuation1/6
  • P/E above its 5-year median

    HCA Healthcare's P/E of 16.8 is above its own 5-year median of 14.4.

  • P/E below the industry

    HCA Healthcare's P/E of 16.8 is below the Health Services median of 23.9.

  • EV/EBITDA above its 5-year median

    HCA Healthcare's EV/EBITDA of 10.0 is above its 5-year median of 9.0.

  • P/S above the industry

    HCA Healthcare's price-to-sales of 1.34 is above the Health Services median of 1.05 (book value is negative, so we use sales).

  • Trading above fair value

    The share price of $506.04 is above our fair value estimate of $495.17.

  • Margin of safety under 20%

    The price is 2.2% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 13.9% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 6.8% over the last twelve months, against a 5-year average of 12.6% a year.

  • Growing faster than the industry

    Revenue grew 5.8% over the last twelve months; the Health Services median is 4.0%.

  • Guidance lowered

    HCA Healthcare lowered its 2026 EPS (diluted) outlook on Jul 14, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings grew over 5 years

    Net income grew 12.6% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 8.6% over the last twelve months, against a 5-year average of 9.3%.

  • Net margin above the industry

    HCA Healthcare's net margin of 8.6% is above the Health Services median of -2.6%.

Financial health1/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 22.1% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets don't cover short-term debts

    Current assets are 0.82 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 1.93; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    HCA Healthcare paid dividends worth 0.6% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.6% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; HCA Healthcare yields 0.6%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 8 fiscal years.

  • Covered by earnings

    Dividends take 10.1% of net income.

  • Covered by free cash flow

    Dividends take 11.4% of free cash flow.

Scores of similar companies

Our estimate per share

$495.17

The share price is 2% above this estimate.

20%+ below
Near fair value
20%+ above
$506.04Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E19.1×14.4×23.9×$577.1244%
EV/EBITDA8.8×9.0×8.6×$431.7839%
Earnings power8.5% cost of equity––$424.5417%
Fair value$495.17100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 14.4
  • Health Services median 23.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$623.01M
Value traded per 1% price move
$424.06M

Downside

Medium risk

Typical loss in a bad month
15.3%
Volatility (annualized)
33%
Sharpe ratio, 1 year
0.18
Beta to the S&P 500 (5Y)
0.73

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Net margin

9.0%+1.7 pts over 5 years

See a number that looks wrong?